Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
26.80
0.00 (0.00%)
Jul 28, 2025, 8:00 PM EDT
TKPHF Market Cap
TKPHF has a market cap or net worth of $45.21 billion as of July 30, 2025. Its market cap has increased by 9.78% in one year.
Market Cap
45.21B
Enterprise Value
76.92B
Revenue
30.60B
Ranking
n/a
PE Ratio
62.73
Stock Price
$26.80
Market Cap Chart
Since January 14, 1992, TKPHF's market cap has increased from 8.47B to 45.21B, an increase of 433.71%. That is a compound annual growth rate of 5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 45.11B | 6.97% |
| Dec 30, 2024 | 42.17B | -6.54% |
| Dec 29, 2023 | 45.12B | -6.90% |
| Dec 30, 2022 | 48.46B | 14.20% |
| Dec 30, 2021 | 42.44B | -25.32% |
| Dec 30, 2020 | 56.83B | -8.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 794.80M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 586.78M |
| Glass House Brands | 435.01M |
| Northwest Biotherapeutics | 372.10M |
| CytoDyn | 355.85M |